Stock FBLG FIBROBIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights FibroBiologics, Inc.

Equities

FBLG

US31573L1052

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-31 EDT 		5-day change 1st Jan Change
12.18 USD -1.14% Intraday chart for FibroBiologics, Inc. +6.10% -.--%
05-14 FibroBiologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FibroBiologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids
CI
Fibrobiologics Presents Data from Dermal Fibroblast Spheroid-Based Treatment of Chronic Wounds in A Diabetes Mouse Model At Advanced Wound Care Summit USA
CI
FibroBiologics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
FibroBiologics, Inc. to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis Forum
CI
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FBLG Stock
  4. News FibroBiologics, Inc.
  5. Highlights